Medication info
Lipistat Tablets 20 mg (Atorvastatin Calcium Hydrate)

Lipistat Tablets 20 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Hydrate›21.7mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201603432 · Approved 2016.06.14 · Insurance code 661904670

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (40 mg only for patients requiring an LDL cholesterol reduction of 45 % or greater). This medicine is administered at doses ranging from 10~80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2~4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when starting treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10~80 mg once daily. Administer it in combination with other lipid-lowering therapies (e.g., LDL apheresis), or when such therapies are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (10~17 years): The recommended initial dose of this medicine is 10 mg daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the treatment goal recommended for each patient. Adjust the dose at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • hyperlipidemia
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
View approved original text

This medication helps reduce the risk of myocardial infarction, stroke, vascular procedures, stable angina, and hospitalization due to congestive heart failure in adults with cardiovascular risk factors and patients with type 2 diabetes. It is also used to lower total cholesterol and LDL-cholesterol, while increasing HDL-cholesterol, in patients with primary hypercholesterolemia and mixed dyslipidemia, thus improving blood lipid profiles. It is effective even in cases where hyperlipidemia is poorly controlled and is particularly useful as an adjunct therapy for lowering cholesterol levels in children with heterozygous familial hypercholesterolemia. In summary, this medication is effectively used for hyperlipidemia and reducing the risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (40 mg only for patients requiring an LDL cholesterol reduction of 45 % or greater). This medicine is administered at doses ranging from 10~80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2~4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when starting treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10~80 mg once daily. Administer it in combination with other lipid-lowering therapies (e.g., LDL apheresis), or when such therapies are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (10~17 years): The recommended initial dose of this medicine is 10 mg daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the treatment goal recommended for each patient. Adjust the dose at intervals of 4 weeks or longer.

Precautions

This medication may cause adverse muscle reactions, so if severe muscle pain or weakness occurs, discontinue use immediately and consult a physician. Due to potential effects on liver function, do not take this medication if you have liver disease or elevated liver enzyme levels. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication and should use appropriate contraception while on it. This medication should not be administered to children, especially those under 10 years of age. Individuals with alcoholism or a history of liver disease should use this medication with caution and undergo regular liver function tests. This medication may interact with certain drugs, so inform a physician or pharmacist if you are taking other medications. Be cautious when taking this medication with foods or drugs that inhibit the CYP3A4 enzyme, like grapefruit juice, as it may increase blood concentrations of this medication, raising the risk of side effects. If you experience severe muscle pain, weakness, fatigue, accompanied by fever or malaise, contact a physician immediately for testing. If symptoms of hepatitis such as nausea, vomiting, fatigue, or jaundice occur while taking this medication, discontinue use immediately and seek medical attention. Elderly patients or those with renal function impairment are at higher risk for myopathy, requiring additional caution during use. In the event of an overdose, there are no specific antidotes, so seek medical treatment immediately for symptomatic care and undergo liver and muscle-related testing. Store in a place out of reach of children, and keep in the original container tightly sealed.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • pharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 169 more
  • loss of appetite
  • constipation
  • abdominal distention
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngodynia
  • laryngodynia
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • perceptual abnormalities
  • sensory loss
  • taste disturbances
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocyte
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • vertigo
  • phototoxic reaction
  • drowsiness
  • memory impairment
  • abnormal dreams
  • decreased libido
  • emotional disturbance
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • tension
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia
  • tendon contraction
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • nephrolithiasis
  • nocturia
  • epididymitis
  • fibrocystic breasts
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • hypoglycemia
  • increased appetite
  • vasomotor edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • systemic edema
  • amblyopia
  • dry eyes
  • refractive errors
  • retinal hemorrhage
  • hearing loss
  • glaucoma
  • hypogeusia
  • ageusia
  • leukopenia
  • anemia
  • low testosterone
  • increased cholinesterase
  • elevated TSH
  • increased ACTH
  • decreased aldosterone
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. Additionally, it is recommended to store the medication at room temperature between 1 to 30 degrees Celsius, avoiding excessively hot or cold conditions.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.